No Data
No Data
The EU may unconditionally approve novo-nordisk a/s's acquisition of catalent.
The European Commission may unconditionally approve novo-nordisk a/s's parent company, Novo Holdings, to acquire the usa contract pharmaceutical company catalent for 16.5 billion USD.
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Novo Slated to Win EU Approval for Catalent Takeover, Reuters Says
EU Antitrust Regulators Expected to Approve Novo Holdings' $16.5B Acquisition of Catalent Without Conditions
Catalent Stock Soars to 52-week High, Hits $61.32
Market Climbs, Bitcoin Close to $100k | Live Stock